Azithromycin and Hepatic Function Abnormal

This page shows results related to Azithromycin and Hepatic Function Abnormal from the FDA Adverse Event Reporting System (AERS).

Adverse Event

Safe Use Tools

Learn More

Comments

Azithromycin and Hepatic Function Abnormal

Age

>60 Years	14
30-39 Years	11
40-49 Years	7
20-29 Years	5
10-19 Years	4
50-59 Years	4

Gender

Male: 39%
Female: 51%
Gender Unknown: 10%

Outcome

What were the most common outcomes of those reporting Hepatic Function Abnormal?

Hospitalization	53
Other	30
Life Threatening	12
Death	4
Disability	1

Reporter

Who most commonly reported Hepatic Function Abnormal?

Physician	47
Pharmacist	8
Other	4
Consumer	2

Therapy

Of those reporting Hepatic Function Abnormal, why were they taking Azithromycin?

Pneumonia	11
Ill-defined Disorder	9
Asthma	8
Nasopharyngitis	6
Bronchitis	4

Other Medications

Which medications reported to the FDA are most commonly associated with Hepatic Function Abnormal?

Nexavar	2122
Iressa	385
Lipitor	334
Remicade	302
Humira	246
	Show More
Tegretol	245
Neoral	244
Prednisolone	242
Methotrexate	236
Acetaminophen	224
Lamictal	205
Cymbalta	188
Crestor	183
Tracleer	182
Lamivudine	177
Cyclosporine	177
Arava	162
Fosamax	159
Revlimid	159
Lamisil	157
Exjade	156
Diovan	154
Cyclophosphamide	153
Plavix	143
Aspirin	142
Norvir	140
Seroquel	136
Prograf	133
Itrizole	132
Clarithromycin	131
Paxil	126
Meropenem	124
Voltaren	124
Zyprexa	124
Vfend	123
Enbrel	123
Fenofibrate	122
Efavirenz	119
Rheumatrex	118
Velcade	117
Kaletra	115
Tocilizumab	112
Temodal	112
Sutent	110
Lyrica	110
Immucyst	110
Micardis	108
Trisenox	107
Cytarabine	104
Norvasc	104
Tamiflu	103

Is the adverse drug reaction you’re experiencing actually due to the drug you took?

The Naranjo Scale is a questionnaire for determining the likelihood of whether an adverse drug reaction is actually due to the drug or caused by other factors. Probability is assigned via a score termed definite, probable, possible or doubtful.^*

	YES	NO	UNKOWN
Are there previous conclusive reports on this reaction?
Did the adverse event appear after the suspected drug was administered?
Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?
Did the adverse reaction reappear when the drug was readministered?
Are there alternative causes (other than the drug) that could on their own have caused the reaction?
Did the reaction reappear when a placebo was given?
Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?
Was the reaction more severe when the dose was increased, or less severe when the dose was decreased?
Did the patient have a similar reaction to the same or similar drugs in any previous exposure?
Was the adverse event confirmed by any objective evidence?

Probability of an Adverse Event

Doubtful

Possible

Probable

Definite

^*Naranjo, et al. "A method for estimating the probability of adverse drug reactions." Clin Pharmacol Ther. 1981 Aug;30(2):239-45.

To learn more about all adverse events for Azithromycin, view the complete Azithromycin adverse event report.

Scientific Publications on Hepatic Function Abnormal

Comments

Share your experience with Azithromycin and Hepatic Function Abnormal.